A light-induced hydrogel responsive platform to capture and selectively isolate single circulating tumor cells. Issue 9 (16th February 2022)

• Record Type: Journal Article
• Authors: Chen, Bei; Wang, Ganggang; Huang, Chunyu; Sun, Yue; Zhang, Jing; Chai, Zhuomin; Guo, Shi-Shang; Zhao, Xing-Zhong; Yuan, Yufeng; Liu, Wei
• Is Part Of: Nanoscale. Volume 14:Issue 9(2022)
• Page Start: 3504
• Page End: 3512
• Publication Date: 2022-02-16
• Subjects: Nanoscience -- Periodicals; Nanotechnology -- Periodicals; 620.505
• DOI: 10.1039/d1nr06876h
• Languages: English
• ISSNs: 2040-3364

Abstract

Abstract : This work proposed a new method to selectively isolate single circulating tumor cells by combining a Gnp substrate with a photocurable hydrogel. Abstract : Isolation of circulating tumor cells (CTCs) from patients is a challenge due to the rarity of CTCs. Recently, various platforms to capture and release CTCs for downstream analysis have been developed. However, most of the reported release methods provide external stimuli to release all captured cells, which lead to lack of specificity in the pool of collected cells, and the external stimuli may affect the activity of the released cells. Here, we presented a simple method for single-cell recovery to overcome the shortcomings, which combined the nanostructures with a photocurable hydrogel, chondroitin sulfate methacryloyl (CSMA). In brief, we synthesized gelatin nanoparticles (Gnps) and modified them on flat glass (Gnp substrate) for the specific capture of CTCs. A 405 nm laser was projected onto the selected cells, and then CSMA was cured to encapsulate the selected CTCs. Unselected cells were removed with MMP-9 enzyme solution, and selected CTCs were recovered using a microcapillary. Finally, the photocurable hydrogel-encapsulated cells were analyzed by nucleic acid detection. In addition, the results suggested that the isolation platform showed good biocompatibility and successfully achieved the isolation of selected cells. In summary, our light-induced hydrogel responsive platform holds certain potential for clinical applications.